Literature DB >> 9014781

Adding interventions to interferon in chronic HCV infections.

J Main1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 9014781      PMCID： PMC1383407          DOI： 10.1136/gut.39.5.769

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  10 in total

1.  Alpha interferon treatment may prevent hepatocellular carcinoma in HCV-related liver cirrhosis.

Authors:  G Mazzella; E Accogli; S Sottili; D Festi; M Orsini; A Salzetta; V Novelli; A Cipolla; C Fabbri; A Pezzoli; E Roda
Journal:  J Hepatol       Date:  1996-02       Impact factor: 25.083

2.  A pilot study of combination therapy with ribavirin plus interferon alfa for interferon alfa-resistant chronic hepatitis C.

Authors:  S Brillanti; J Garson; M Foli; K Whitby; R Deaville; C Masci; M Miglioli; L Barbara
Journal:  Gastroenterology       Date:  1994-09       Impact factor: 22.682

Review 3.  Prospectives on the treatment of chronic hepatitis B and chronic hepatitis C with thymic peptides and antiviral agents.

Authors:  M G Mutchnick; M N Ehrinpreis; J L Kinzie; R R Peleman
Journal:  Antiviral Res       Date:  1994-07       Impact factor: 5.970

4.  The effect of interferon alfa and ribavirin combination therapy in naive patients with chronic hepatitis C.

Authors:  L Chemello; L Cavalletto; E Bernardinello; M Guido; P Pontisso; A Alberti
Journal:  J Hepatol       Date:  1995       Impact factor: 25.083

5.  Combination low-dose lymphoblastoid interferon and thymosin alpha 1 therapy in the treatment of chronic hepatitis B.

Authors:  G Rasi; M G Mutchnick; D Di Virgilio; P Sinibaldi-Vallebona; P Pierimarchi; F Colella; C Favalli; E Garaci
Journal:  J Viral Hepat       Date:  1996-07       Impact factor: 3.728

6.  Evaluation of efficacy and safety of thymus humoral factor-gamma 2 in the management of chronic hepatitis B.

Authors:  B A Farhat; G Marinos; H M Daniels; N V Naoumov; R Williams
Journal:  J Hepatol       Date:  1995-07       Impact factor: 25.083

7.  Ribavirin treatment for chronic hepatitis C.

Authors:  O Reichard; J Andersson; R Schvarcz; O Weiland
Journal:  Lancet       Date:  1991-05-04       Impact factor: 79.321

8.  Chronic hepatitis C virus infections: predictive value of genotype and level of viraemia on disease progression and response to interferon alpha.

Authors:  J C Booth; G R Foster; U Kumar; R Galassini; R D Goldin; J L Brown; H C Thomas
Journal:  Gut       Date:  1995-03       Impact factor: 23.059

9.  A comparison of three interferon alfa-2b regimens for the long-term treatment of chronic non-A, non-B hepatitis. Multicenter Study Group.

Authors:  T Poynard; P Bedossa; M Chevallier; P Mathurin; C Lemonnier; C Trepo; P Couzigou; J L Payen; M Sajus; J M Costa
Journal:  N Engl J Med       Date:  1995-06-01       Impact factor: 91.245

10.  Randomised trial of effects of interferon-alpha on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis.

Authors:  S Nishiguchi; T Kuroki; S Nakatani; H Morimoto; T Takeda; S Nakajima; S Shiomi; S Seki; K Kobayashi; S Otani
Journal:  Lancet       Date:  1995-10-21       Impact factor: 79.321
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.